Your program needs a supply chain behind it.
Supply is the first thing a clinic tries to solve alone and the first thing that goes wrong. Inside the program, the accounts are opened for you and mapped to the compounds you actually intend to carry.
Prepared for one named patient,
against one valid prescription.
What gets opened, and by whom
Revival RX Partners is not a pharmacy. We hold relationships with licensed 503A compounding pharmacies and, where a compound and a state allow it, 503B outsourcing facilities. During Days 1–30 we open the right accounts on the clinic's behalf, against the specific menu the clinic has decided to carry and the states its prescribers are licensed in. The clinic does not spend six weeks cold-calling pharmacies and comparing intake packets.
Fulfilment runs directly between the partner pharmacy and the patient or clinic, depending on the compound and the prescription. We do not take possession of medication at any point, and we do not sit in the shipping path.
503(a) and 503(b), and why the difference decides your menu
A 503(a) pharmacy compounds for one identified patient against a valid prescription. It cannot prepare product in advance for office stock. A 503(b) outsourcing facility is FDA-registered, compounds in batches under CGMP requirements, and can supply for office use in defined circumstances. Which one applies changes what a clinic can hold, how it orders, and how it schedules patients.
Most peptide protocols follow the 503(a) path. That is not a limitation to work around — it is a constraint the whole program is designed against, which is why inventory planning and patient scheduling are built in the same thirty days as the sourcing accounts.
The catalog, and what we will not say about it
The partner network covers recovery and tissue compounds, growth hormone secretagogues, metabolic and longevity categories, premixed and dry formulations, and peptide pens where a partner offers them. Availability varies by compound, by pharmacy, and by state, and it changes — substances move between FDA bulk-substance categories and facilities adjust what they will prepare in response.
We describe compounds by category. We do not make claims about clinical outcomes for compounded preparations, and compounded peptides are not FDA-approved products. What a clinic prescribes is a decision for its licensed practitioners.
Preferred pricing, and what it actually is
Launch Program clinics receive preferred pricing across the partner catalog for twelve months following enrolment. It is a partnership term, not a coupon: the specific pricing depends on compound, partner pharmacy, and volume, and it is confirmed during onboarding rather than published.
After the ninety days
The accounts are the clinic's. Reorders run directly. Sourcing support continues — new compounds entering the partner network, substitutions when a facility stops preparing something, and the operational questions that come up when a program grows past its first hundred patients.
Sourcing questions.
Can we buy sourcing without the program?
Who actually dispenses the medication?
What happens if a compound becomes unavailable?
Do we need our own prescriber to order?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.